亨廷顿病病理学的双轨模型:状缩调解了不适应性免疫失调
H Jeremy Bockholt1,2,3,4, Jordan D Clemsen1, Bradley T Baker1
1Center for Translational Research in Neuroimaging and Data Science (TReNDS), Georgia State University, Atlanta, GA 30303, USA.
International journal of molecular sciences
|March 14, 2026
概括
亨廷顿病 (HD) 病理包括两个轨道:轴突损伤 (NEFL) 和免疫失调 (TNFRSF8). 状缩驱动免疫系统的变化,为HD提供了新的生物标志物标.
科学领域:
- 神经科学是一个神经科学.
- 蛋白质组学是指蛋白质组学.
- 免疫学 免疫学 免疫学
背景情况:
- 亨廷顿病 (HD) 是一种神经退行性疾病,其特征是渐进的条纹性缩和复杂的蛋白质基因变化.
- 了解灰质损失的生物学相关性对于开发有效的治疗策略至关重要.
研究的目的:
- 用脑脊液 (CSF) 的超敏感蛋白质分析剖析亨廷顿病中灰质损失的生物相关物.
- 为了研究神经退行症标记物,免疫信号和HD患者的条纹体积之间的关系.
主要方法:
- 88名亨廷顿病 (HD) 患者的脑脊髓液 (CSF) 使用下一代超敏感免疫检测 (NULISA) 蛋白质组平台进行了分析.
- 评估了蛋白质水平 (NEFL,TNFRSF8) 和条纹体积 (putamen) 之间的相关性,控制了遗传负担和性别.
- 调解分析被用来探索遗传负担,条状缩和免疫失调之间的因果关系.
主要成果:
- 确定了一种"双轨道"病理模型:轨道1显示神经丝光链 (NEFL) 与轴突损伤和反向条纹体积相关.
- 轨道2揭示了TNFRSF8 (CD30),一种免疫调节剂,与条纹体积积极相关,表明免疫信号与缩的下降.
- TNFRSF8独立地与条状体体积相关,条状体缩介导了遗传负担和免疫失调之间的联系,特别是在条状体中.
结论:
- 不适应性免疫信号传递是亨廷顿病的独特病理相关物,可以与一般细胞骨损伤分离.
- 确定了涉及神经退行和免疫失调的双轴框架,为开发新生物标志物和治疗目标提供了潜力.
- 需要进一步的纵向和干预研究来验证这种结构-免疫轴,以对患者分层和治疗监测进行验证.
关键词:
亨廷顿病就是亨廷顿病.努利萨 (Nulisa) 是一个无关紧要的人.生物标志物 生物标志物神经免疫轴的神经免疫轴神经退行症的神经退行症神经炎症是一种神经炎症.蛋白质组学 蛋白质组学条纹体的条纹体.更多相关视频
09:46Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
5.3K
08:27Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
Published on: March 11, 2020
6.7K
相关概念视频
Encephalitis ll: Pathophysiology
22
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
22
Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28
Huntington Disease l: Introduction
110
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
110
